Figure 1.
Participant flow. FIRST, Ferriprox in Patients with Iron Overload in Sickle Cell Disease Trial; ITT, intent-to-treat; SCD, sickle cell disease.
Participant flow. FIRST, Ferriprox in Patients with Iron Overload in Sickle Cell Disease Trial; ITT, intent-to-treat; SCD, sickle cell disease.
